Asmita Mishra

Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of <i>FLT3</i>

Mark J. Levis, Mehdi Hamadani, Brent R. Logan et al. · Journal of Clinical Oncology · 2024 · 153 citations · Full text

Biologic Assignment Trial of Reduced-Intensity Hematopoietic Cell Transplantation Based on Donor Availability in Patients 50-75 Years of Age With Advanced Myelodysplastic Syndrome

Ryotaro Nakamura, Wael Saber, Michael J. Martens et al. · Journal of Clinical Oncology · 2021 · 133 citations · Full text

Eprenetapopt Plus Azacitidine After Allogeneic Hematopoietic Stem-Cell Transplantation for <i>TP53</i>-Mutant Acute Myeloid Leukemia and Myelodysplastic Syndromes

Asmita Mishra, Roni Tamari, Amy E. DeZern et al. · Journal of Clinical Oncology · 2022 · 131 citations

Safety at the Time of the COVID-19 Pandemic: How to Keep Our Oncology Patients and Healthcare Workers Safe

Pelin Cinar, Timothy Kubal, Alison G. Freifeld et al. · Journal of the National Comprehensive Cancer Network · 2020 · 116 citations · Full text

Healthcare Workers Safe, Safety Science, Population Health Sciences +20

Outcome of patients with low‐risk and intermediate‐1‐risk myelodysplastic syndrome after hypomethylating agent failure: A report on behalf of the MDS Clinical Research Consortium

Elias Jabbour, Guillermo Garcia‐Manero, Paolo Strati et al. · Cancer · 2014 · 108 citations · Full text